ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 716 filers reported holding ASTRAZENECA PLC in Q3 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,455,124 | -3.8% | 287,288 | +1.7% | 0.08% | +4.0% |
| Q2 2023 | $20,219,113 | +0.9% | 282,514 | -2.1% | 0.08% | -3.8% |
| Q1 2023 | $20,035,624 | -49.0% | 288,654 | -50.1% | 0.08% | -1.3% |
| Q4 2022 | $39,252,328 | +144.2% | 578,875 | +97.5% | 0.08% | +11.3% |
| Q3 2022 | $16,077,000 | +25.3% | 293,160 | +46.4% | 0.07% | +18.3% |
| Q2 2022 | $12,834,000 | +0.1% | 200,222 | +3.6% | 0.06% | +5.3% |
| Q1 2022 | $12,822,000 | +7.3% | 193,265 | -5.8% | 0.06% | +14.0% |
| Q4 2021 | $11,952,000 | -10.3% | 205,199 | -7.5% | 0.05% | -16.7% |
| Q3 2021 | $13,320,000 | +10.6% | 221,755 | +10.3% | 0.06% | +13.2% |
| Q2 2021 | $12,038,000 | +20.0% | 200,978 | -0.4% | 0.05% | +23.3% |
| Q1 2021 | $10,032,000 | -10.6% | 201,768 | -10.1% | 0.04% | -12.2% |
| Q4 2020 | $11,219,000 | -15.3% | 224,451 | -7.1% | 0.05% | -24.6% |
| Q3 2020 | $13,242,000 | -0.9% | 241,621 | -4.3% | 0.06% | -9.7% |
| Q2 2020 | $13,357,000 | +12.6% | 252,567 | -4.9% | 0.07% | +2.9% |
| Q1 2020 | $11,859,000 | -3.7% | 265,550 | +7.6% | 0.07% | +20.7% |
| Q4 2019 | $12,311,000 | +10.3% | 246,903 | -1.4% | 0.06% | +3.6% |
| Q3 2019 | $11,163,000 | +5.8% | 250,447 | -2.1% | 0.06% | +1.8% |
| Q2 2019 | $10,555,000 | +1.8% | 255,694 | -0.3% | 0.06% | +1.9% |
| Q1 2019 | $10,368,000 | -2.8% | 256,419 | -8.7% | 0.05% | -11.5% |
| Q4 2018 | $10,664,000 | -10.1% | 280,744 | -6.3% | 0.06% | +3.4% |
| Q3 2018 | $11,861,000 | +13.0% | 299,757 | +0.2% | 0.06% | +3.5% |
| Q2 2018 | $10,500,000 | -2.0% | 299,085 | -2.4% | 0.06% | -1.7% |
| Q1 2018 | $10,712,000 | -2.6% | 306,309 | -3.4% | 0.06% | 0.0% |
| Q4 2017 | $11,003,000 | +2.9% | 317,119 | +0.5% | 0.06% | 0.0% |
| Q3 2017 | $10,688,000 | -1.6% | 315,443 | -1.0% | 0.06% | -9.4% |
| Q2 2017 | $10,860,000 | +9.5% | 318,571 | -0.0% | 0.06% | +6.7% |
| Q1 2017 | $9,922,000 | +18.2% | 318,619 | +3.7% | 0.06% | +15.4% |
| Q4 2016 | $8,397,000 | -75.9% | 307,320 | -71.0% | 0.05% | -76.6% |
| Q3 2016 | $34,802,000 | +11.7% | 1,059,096 | +2.7% | 0.22% | +5.7% |
| Q2 2016 | $31,143,000 | +26.7% | 1,031,558 | +18.2% | 0.21% | +26.5% |
| Q1 2016 | $24,573,000 | -6.4% | 872,594 | +12.8% | 0.17% | -4.6% |
| Q4 2015 | $26,255,000 | +13.3% | 773,375 | +6.2% | 0.17% | +10.1% |
| Q3 2015 | $23,181,000 | +264.2% | 728,489 | +629.0% | 0.16% | +315.8% |
| Q2 2015 | $6,365,000 | +1.6% | 99,929 | +9.2% | 0.04% | -2.6% |
| Q1 2015 | $6,263,000 | -2.7% | 91,529 | +0.1% | 0.04% | -2.5% |
| Q4 2014 | $6,436,000 | +3.8% | 91,442 | +5.4% | 0.04% | 0.0% |
| Q3 2014 | $6,200,000 | +2067.8% | 86,787 | +2157.7% | 0.04% | +233.3% |
| Q2 2014 | $286,000 | -16.9% | 3,844 | -27.4% | 0.01% | -14.3% |
| Q1 2014 | $344,000 | +2.1% | 5,293 | -6.8% | 0.01% | 0.0% |
| Q4 2013 | $337,000 | +11.2% | 5,682 | -2.6% | 0.01% | 0.0% |
| Q3 2013 | $303,000 | +12.2% | 5,833 | +2.2% | 0.01% | +7.7% |
| Q2 2013 | $270,000 | – | 5,707 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |